Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-23-023991

Chief Executive Officer acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Seehra Jasbir · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-08 Exercise or conversion : show line 1 in the form +4,000 $0.48 $1,920 252,856 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-08 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −4,000 45,087 D
Loading xslF345X04/doc4.xml…